作者: Ernest T. Hawk , Asad Umar , Jaye L. Viner
DOI: 10.1053/J.GASTRO.2004.03.002
关键词: Intraepithelial neoplasia 、 Intensive care medicine 、 Cancer screening 、 Preventive healthcare 、 Relative risk 、 Medicine 、 Gynecology 、 Cancer prevention 、 Colorectal cancer 、 Clinical trial 、 Population
摘要: The development and dissemination of sophisticated detection technologies have recently exposed the high prevalence preinvasive colorectal neoplasia in adult U.S. population. Although cancer screening surveillance provide opportunities for risk stratification, they achieve reduction only when coupled with effective interventions. This review surveys lead compounds prevention measures by which may be prioritized clinical testing. Clinical trials remain rate-limiting step agent development, novel trial designs are needed to hasten identification testing prevention. Innovative research models include nesting end points within treatment promising preventive intended nononcologic indications.